An expert panel voted 13-10 Tuesday recommending the U.S. Food and Drug Administration grant emergency use authorization to a new drug developed by Merck to treat mild to moderate COVID-19 in unvaccinated patients. Read more»
to our supporters
- John S. and James L. Knight Foundation
- Ida B. Wells
- Fund for Investigative Journalism
- Edna Gray
- Tucson Police Department
- Ann-Eve Dingell
- Margaret Fuller
- Linda Seberger
- Maggie Golston
- Edward Smith
- & many more!
We rely on readers like you. Join them & contribute to the Sentinel today!
The FDA’s 19-member Vaccines and Related Biological Products Advisory Committee voted unanimously Friday to recommend that everyone who received the COVID-19 vaccine developed by Johnson and Johnson receive a second dose at least two months after the first jab. Read more»
election legislature republicans aztecs pcc congress joe biden coronavirus supreme court health care pima county donald trump cbp immigration budget democrats ua taxes border patrol jobs senate drugs ice economy texas